유유제약, 보유 자사주 전량 소각…개정상법 앞두고 주주환원 강화

Yuyu Pharma's proactive cancellation of treasury stock ahead of expected commercial law revisions demonstrates a commitment to strengthening shareholder returns and corporate value. This move reflects broader industry trends toward improved corporate governance and capital management in Korea, positioning the company favorably for upcoming regulatory changes.